Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
11/05/1996 | US5571786 Analgesics and antiinflammatory agents |
11/05/1996 | US5571530 Respiratory system disorders by administering beta receptors for treatment of bronchitis |
10/31/1996 | WO1996034099A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
10/31/1996 | WO1996033993A1 Antithrombotic amidinotetrahydropyridylalanine derivatives |
10/31/1996 | WO1996033713A1 Indazolecarboxamides |
10/31/1996 | WO1996033710A1 A combination of a 5-ht uptake inhibitor with a selective 5-ht1a antagonist |
10/31/1996 | WO1996033703A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
10/31/1996 | WO1996033701A1 Inhibiting photodecomposition of 3-substituted-2-oxindoles |
10/31/1996 | WO1996033678A1 Triacetin as a transdermal penetration enhancer |
10/31/1996 | CA2219261A1 Antithrombotic amidinotetrahydropyridylalanine derivatives |
10/31/1996 | CA2219214A1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
10/31/1996 | CA2218181A1 A combination of a 5-ht uptake inhibitor with a selective 5-ht1a antagonist |
10/31/1996 | CA2217696A1 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
10/31/1996 | CA2215359A1 Indazolecarboxamides |
10/30/1996 | EP0739892A2 Chromone derivatives |
10/30/1996 | EP0739347A1 Hydrazides of phosphorylated carboxylic acids having therapeutic activity |
10/30/1996 | EP0739342A1 Pyridine modulators of acetylcholine receptors |
10/30/1996 | EP0739336A1 Gem-disubstituted azacyclic tachykinin antagonists |
10/30/1996 | EP0739200A1 Therapeutic substituted guanidines |
10/30/1996 | EP0695301B1 Indole derivatives as 5-ht1-like agonists for use in migraine |
10/30/1996 | CN1134705A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
10/30/1996 | CN1134699A Succinamic acid compound, process for producing the same, and use thereof |
10/30/1996 | CN1134670A Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide |
10/30/1996 | CN1134669A Use of thiazolidinediones to prevent or delay onset of NIDDM |
10/30/1996 | CN1134663A New emulsion formulation |
10/30/1996 | CN1134422A Improved process for large-scale production of BMS 180048 and analogs |
10/30/1996 | CN1134300A Medicinal capsule for replenishing vital essence and marrow, beautifying and antisenility |
10/29/1996 | US5569669 Treating anxiety, depression |
10/29/1996 | US5569661 Process for the production of b-carbolines |
10/29/1996 | US5569655 Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof |
10/29/1996 | US5569653 N-[(4-(heteroaryl)-1-pyrrolidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility |
10/29/1996 | US5569648 Administering insulin-like growth factor |
10/29/1996 | CA2057912C (1,2n) and (3,2n)-carbocyclic-2-amino tetralin derivatives |
10/29/1996 | CA1338683C Fatty acid therapy and compositions |
10/24/1996 | WO1996033273A1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions |
10/24/1996 | WO1996033268A1 Apopain |
10/24/1996 | WO1996033194A1 Benzimidazole compounds and their use as modulators of the gaba a receptor complex |
10/24/1996 | WO1996033192A1 Benzimidazole compounds and their use as modulators of the gabaa receptor complex |
10/24/1996 | WO1996033191A1 Benzimidazole compounds and their use as modulators of the gabaa receptor complex |
10/24/1996 | WO1996033186A1 Substituted dihydrobenzofuran derivatives as 5-ht4 agonists |
10/24/1996 | WO1996033177A1 3-phenyl-1,4-dialkyl-1,2,4-triazolium salts and their use as antidepressants |
10/24/1996 | WO1996033175A1 Cyclic amidino agents useful as nitric oxide synthase inhibitors |
10/24/1996 | WO1996033169A1 1-[φ-(3,4-DIHYDRO-2-NAPHTHALENYL)ALKYL] CYCLIC AMINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION CONTAINING THE SAME |
10/24/1996 | WO1996033165A1 Derivatives of succinamide and their use as metalloproteinase inhibitor |
10/24/1996 | WO1996033161A1 Derivatives of succinamide and their use as metalloproteinase inhibitors |
10/24/1996 | WO1996032965A1 Cd45rb binding compounds for the prevention of transplant rejection |
10/24/1996 | WO1996032959A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same |
10/24/1996 | WO1996032948A1 Method for treating dyskinesias |
10/24/1996 | WO1996032944A1 Method for using ergoline compounds to effect physiological and pathological functions at the 5-ht7 receptor |
10/24/1996 | WO1996032939A1 USE OF α1L AGONISTS IN THE TREATMENT OF INCONTINENCE |
10/24/1996 | WO1996029315A3 Imidazole derivatives as histamine receptor h3 (ant)agonists |
10/24/1996 | WO1996023769A3 Heterocyclic compounds possessing 5ht2c receptor antagonist activity |
10/24/1996 | DE19514579A1 Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz Using alpha¶1¶¶L¶ agonists for treating urinary incontinence |
10/24/1996 | CA2218679A1 Apopain |
10/24/1996 | CA2218599A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same |
10/24/1996 | CA2218330A1 1- .omega.-(3,4-dihydro-2-naphthalenyl)alkyl -cyclic amine derivatives, process for preparing the same, and pharmaceutical composition containing the same |
10/24/1996 | CA2218143A1 Method for using ergoline compounds to effect physiological and pathological functions at the 5-ht7 receptor |
10/24/1996 | CA2218062A1 Method for treating dyskinesias |
10/24/1996 | CA2216882A1 Cyclic amidino agents useful as nitric oxide synthase inhibitors |
10/23/1996 | EP0738722A1 5-Amino-benzofuran-2-carboxylic acid derivatives |
10/23/1996 | EP0738717A1 Certain substituted pyrimidines as intermediates for production of cycloalkyl and azacycloalkyl pyrrolopyrimidines |
10/23/1996 | EP0738514A1 Treatment of dyskinesias |
10/23/1996 | EP0738513A1 Method for using ergoline compounds to effect physiological and pathological functions at the 5-HT7 receptor |
10/23/1996 | EP0738322A1 T cell antigen receptor v region proteins and methods of preparation thereof |
10/23/1996 | EP0738262A1 Novel heterocyclic compounds |
10/23/1996 | EP0738155A1 Modular design and synthesis of oxazolone-derived molecules |
10/23/1996 | EP0738154A1 N-terminus modified analogs of lhrh |
10/23/1996 | EP0738149A1 1-aminoindan derivatives and compositions thereof |
10/23/1996 | EP0738147A1 Application of riluzole in the treatment of mitochondrial diseases |
10/23/1996 | EP0678023B1 Application of riluzole in the treatment of parkinson's disease and parkinsonian syndromes |
10/23/1996 | EP0646110B1 N-substituted 3-azabicyclo[3.2.0]heptane derivatives useful as neuroleptic agents |
10/23/1996 | EP0576643B1 Controlled release oxycodone compositions |
10/23/1996 | EP0517876B1 Therapeutic benzazepine compounds |
10/23/1996 | CN1134149A Phenylindole compounds |
10/23/1996 | CN1134147A 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles useful as memory enhancers |
10/23/1996 | CN1134110A Method for regulating gastrointestinal motility |
10/23/1996 | CN1133844A Osa-or thia-aliphatically bridged quinoxaline-2,3-diones |
10/23/1996 | CN1133843A Thienopyridone |
10/23/1996 | CN1133841A Use of 1,2-bridged 1,4-dihydropyridines as medicaments |
10/23/1996 | CN1133840A Indolepiperidine derivatives |
10/23/1996 | CN1133839A Aroyl-piperidine derivatives |
10/23/1996 | CN1033089C Process for preparation of aryl piperazinyl-heterocyclic compounds |
10/22/1996 | US5567824 Catalyzing the cyclization in presence of a solvent and a proton acceptor |
10/22/1996 | US5567818 Reduction; separation; dehydration |
10/22/1996 | US5567814 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE |
10/22/1996 | US5567726 Selective agonists of 5-hydroxytryptamine-like receptors; useful in treatment of migraine and associated disorders |
10/22/1996 | US5567724 Alkaline and acid phosphatase inhibitors in treatment of neurological disorders |
10/22/1996 | US5567718 2,3-dihydro-1h-isoindole derivatives and their use as serotonin reuptake inhibitors |
10/22/1996 | US5567715 1-benzothiophene derivatives |
10/22/1996 | US5567714 Methods of treating obesity by inhibiting physiological conditions associated with an excess of neuropeptide Y |
10/22/1996 | US5567689 Methods for increasing uridine levels with L-nucleosides |
10/22/1996 | US5567437 Effervescent pharmaceutical composition containing ibuprofen and its method of preparation |
10/22/1996 | US5567425 Plant extracts |
10/22/1996 | CA2007655C Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles |
10/17/1996 | WO1996032395A1 Benzimidazole derivatives |
10/17/1996 | WO1996032393A1 1,2,4-triazolo[4,3-b]pyridazine derivatives and their use |
10/17/1996 | WO1996032392A1 ANELLATED β-CARBOLINES |
10/17/1996 | WO1996032390A1 PREPARATION OF CHIRAL 5-AMINOCARBONYL-5H-DIBENZO-[a,d]CYCLOHEPTEN-5,10-IMINES BY OPTICAL RESOLUTION |
10/17/1996 | WO1996032389A1 4-(6-fluoro-1,2-benzisoxazolyl)-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and anxiety |
10/17/1996 | WO1996032386A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |